LSI is Officially Heading to Singapore — Register for LSI Asia '25 Today
Learn More About NovaDigm Therapeutics
NovaDigm Therapeutics
image
The first vaccine to demonstrate efficacy in reducing the mortality of otherwise highly lethal bloodstream infections due to either Candida or S. aureus (including MRSA)
Technology/product details
Revenue projections
Capital raised to date
Growth strategy
Competing Startups
More

Get a Demo and See the Full Profile

Get a demo today to see profiles of Spineology plus 6164 other startups.

Trusted By The Companies Pioneering What’s Next